India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
India, the country with the largest market availability of antimicrobial fixed-dose combinations (FDCs), banned certain antimicrobial FDCs in September 2018. Our objective was to examine the impact of Government ban on the sales of antimicrobial FDCs.
The sales patterns of 14 of the 26 banned antimicrobial FDCs were analyzed using monthly privat...
Alternative Titles
Full title
India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a1cd68ed9b4f48a0b4010c37937d880c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1cd68ed9b4f48a0b4010c37937d880c
Other Identifiers
ISSN
2052-3211
E-ISSN
2052-3211
DOI
10.1186/s40545-022-00428-w
